Results 221 to 230 of about 54,594 (319)
A detergent-based procedure for the preparation of IgG-like bispecific antibodies in high yield [PDF]
Jyoti Gupta +4 more
openalex +1 more source
ABSTRACT Relapsed/refractory (R/R) mantle cell lymphoma (MCL) remains a therapeutic challenge, particularly in patients with high‐risk features or prior exposure to Bruton's tyrosine kinase inhibitors (BTKis). The advent of T‐cell–redirecting immunotherapies, including chimeric antigen receptor T‐cell (CAR‐T) therapy and bispecific antibodies (BsAbs ...
Santino Caserta +10 more
wiley +1 more source
Missense variants in human forkhead transcription factors reveal determinants of forkhead DNA bispecificity [PDF]
Jessica King +5 more
openalex +1 more source
This EBMT Practice Harmonisation and Guidelines Committee consensus provides practical recommendations for the selection, timing and conduct of allogeneic transplantation in advanced‐stage mycosis fungoides and Sézary syndrome, aiming to optimize outcomes through early multidisciplinary collaboration and evidence‐based decision‐making.
Gandhi Damaj +26 more
wiley +1 more source
Nanobody Therapeutics in Alzheimer's Disease: From Molecular Mechanisms to Translational Approaches. [PDF]
Godugu D +5 more
europepmc +1 more source
OC41 - Glucocorticoid inhibition enables mono- and bispecific CAR-T cells to overcome immunotherapeutic resistance in adrenocortical carcinoma [PDF]
Marc Philipp Schauer +7 more
openalex +1 more source
Therapeutic targeting of chromatin alterations in leukemia and solid tumors
Abstract Alterations in chromatin conformation and post‐translational modification of histones have become increasingly recognized as critical drivers of cancer development, progression, and therapy resistance. Recent advances in drug development have led to the establishment of several highly selective small molecule inhibitors, several of which are ...
Florian Perner +7 more
wiley +1 more source
Non-superagonist CD28-based dual-signal T cell engager targeting. [PDF]
Chen T +12 more
europepmc +1 more source

